IOBT - IO Biotech, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
0.73 0.02 (3.02%) --- 0.0 (0.01%) 0.0 (0.01%) 0.0 (0.31%) 0.04 (5.34%) 0.0 (0.0%) 0.0 (-0.6%)

IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.4
Diluted EPS:
-0.4
Basic P/E:
-1.8855
Diluted P/E:
-1.8855
RSI(14) 1m:
50.0
VWAP:
0.75
RVol:

Events

Period Kind Movement Occurred At

Related News